Michelle Rovner

Mkt Dir.; mom; health & fitness nut, sports fan, adrenaline junkie. It's not who you are that holds you back; it's who you think you are NOT. Tweets are my own

[Michelle Rovner @ChelleRovner]

Great discussion w @DeptVetAffairs on enabling, operationalizing, and scaling #innovation in #healthcare. #ISPORSignal

[ISPOR @ISPORorg]

#Value in #Healthcare: We must take the long view and a “whole health” approach with #innovation. Veterans are in VHA care for decades. Creating value for customers will have an economic impact. #ISPORSignal #HEOR

[Kelly Lenahan @Kellyahan]

Be more transparent in their decision making processes! #ISPORBiosimilars

[Michelle Rovner @ChelleRovner]

Biosimilars-focused Twitter chat happening now on best practices, challenges and opportunities for market access of #biosimilars in different regions worldwide.
@CanBiosimilars @BiosimilarsWG @USBiosimilars
@BiosimCenter @GaBIOnline_ @OnBiosimilars

[Kelly Lenahan @Kellyahan]

In the US, the uptake of biosimilars is largely based on health plans. A study by @jchambers241 et al from @JAMA_current in 2020 found that only 14% of health plans prioritize the biosimilar over the reference product.

https://t.co/z4PdH2QlB0

#ISPORBiosimilars

[Michelle Rovner @ChelleRovner]

@BiosimilarsCouncil @biosimilars101 Inviting you to join the conversation!

[ISPOR @ISPORorg]

#ISPORBiosimilars Chat happening now with @drddawoud @menzies_jeff @LieseBarbier @Catarinaloperei
#biosimilars

[Michelle Rovner @ChelleRovner]

T-5 Minutes! Join the #ISPORBiosimilars Chat! #Biosimilars

[Michelle Rovner @ChelleRovner]

We stand at the precipice of #healthcare, looking out on the possibilities of extraordinary therapies and cures. To bring them to fruition, we must face complex, global, and interconnected challenges. The DIA 2020 Global Annual Meeting will take that focu…https://t.co/9lThB6DKKE

[Kosmas Kretsos @kkretsos]

Great #DIA2019 kickoff, the violin setting our pace towards new therapies!

[Michelle Rovner @ChelleRovner]

Packed house for the #DIA2019 opening plenary!

[Michelle Rovner @ChelleRovner]

Kicking off #DIA2019!!! #MoreThanAMeeting

[Allison Hartsoe @ahartsoe]

Context goes a long way when managing up @ahartsoe and @chellerovner chat about making an impact with #analytics management https://t.co/QkQ1pf6kIB

[Customer Equity AI @AmbitionData]

Get the tactical checklist of what you need to do to manage up from @chellerovner in the Accelerator #podcast #wia https://t.co/K7UHaJ3P8h

[Customer Equity AI @AmbitionData]

Get buy-in for your #analytics with active listening @ahartsoe interviews @chellerovner about strategies for managing up #podcast #wia https://t.co/FEIAaJhfse

[Michelle Rovner @ChelleRovner]

😁💪Chicago Tribune Holiday Givin😀g https://t.co/UmWofOw0b7😅😀

[Michelle Rovner @ChelleRovner]

https://t.co/709zceSODS

[Michelle Rovner @ChelleRovner]

Hope to see some @CALifeSciences members in attendance at @DrugInfoAssn complimentary content preview of #DIA2019. Joins DIA in San Francisco on Nov. 5 to discuss the where, when, and how of #RWE from academic, industry, and regulatory pioneers. https://t.co/lE9ZAJAZZT

[Michelle Rovner @ChelleRovner]

https://t.co/qSS9RO69k8

[Michelle Rovner @ChelleRovner]

If #patientengagement is your area of interest, take a look at the conversations taking place @DrugInfoAssn Measuring Impact in Patient-Centered Drug Development Conference Follow #patient18 #engage4health